Steve Callister
Mr Steve Callister – National Chairman

Steve is Managing Director and Partner of an import wholesale company, dealing with all major retailers in Australia and New Zealand. Former roles include Convenor of St Vincent's Prostate Cancer Support Group, Chairman of the NSW SAC, delegate to the National SAC and Chairman of the NSW Board. Steve became Chairman of PCFA’s Marketing and Fundraising Committee of the National Board in May 2009 and National Deputy Chairman in 2015. Steve was appointed as National Chairman of PCFA in November 2018.

Chris Hall
Mr Chris Hall - Deputy National Chairman
B.Comm. (Hons), CA

Chris joined the Board of PCFA in May 2007 as Finance Director. He is a partner at KPMG and having previously been a member of the firms National Executive Committee and a board member. He was also a member of the Australian Auditing and Assurance Standards board until January 2011. Chris was appointed as Deputy National Chairman of PCFA in November 2018.

Bruce Armstrong
Emeritus Professor Bruce Armstrong AM
BMedSc(Hons), MBBS(Hons), DPhil, FRACP, FFAPHM

Bruce Armstrong is internationally recognised for his research into the causes and prevention of cancer, having published over 600 papers in scientific books and journals. His research has included work into trends in PSA testing in Australia and their effects on prostate cancer incidence and mortality, and the effects of diagnosis and treatment of prostate cancer on men's quality of life.

He contributed extensively to the new Australian guidelines for PSA testing and early management of PSA detected prostate cancer developed by Prostate Cancer Foundation of Australia and Cancer Council Australia.

Bruce is now retired from full-time employment but continues to contribute actively to research, research translation and aspects of health care as an Emeritus Professor at the University of Sydney and an Adjunct Professor at the University of WA.

He has previously occupied, among others, the roles of Commissioner of Health for WA, Deputy Director of the International Agency for Research on Cancer, Director of the Australian Institute of Health and Welfare, Director of Research and Registers at Cancer Council NSW and Head of the University of Sydney School of Public Health. Bruce was made a Member of the Order of Australia in 1998 for his work in cancer epidemiology and a Fellow of the Australian Academy of Science in 2000.

In 2015 he was listed by Thomson Reuters among ~3,000 other scientists as The World's Most Influential Scientific Minds on the basis of their number of highly cited papers published in 2003 to 2013.

Judith Clements
Distinguished Professor Judith Clements AC
BASc, MASc, PhD (Endocrinology)

Judith is the Scientific Director of the Australian Prostate Cancer Research Centre – Queensland (APCRC-Q), a dedicated prostate cancer research centre and a collaboration between the Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT) and the Princess Alexandra Hospital.

She is based at the new Translational Research Institute on the Princess Alexandra Hospital Biomedical Precinct. Judith is the Chair of the virtual national prostate cancer tissue bank – the Australian Prostate Cancer Bio Resource, an important resource that underpins prostate cancer research nationally, and is co-leader of the Queensland node of the international genetics study for prostate cancer, PRACTICAL.

She is a two-time winner of the Alban Gee Prize from the Urological Society of Australasia, and has also been the recipient of the QUT Vice Chancellor's Award for Research Excellence. She was awarded the Queensland Women in Technology Biotech Outstanding Achievement Award for 2012, and the prestigious title of Distinguished Professor, the only woman in QUT's history, in 2013.

She was awarded the Companion of the Order of Australia in 2015.

Mark Frydenberg
Professor Mark Frydenberg AM

Professor Mark Frydenberg is a clinical professor in the Department of Surgery, Faculty of Medicine, Monash University; Clinical Chairman, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Faculty of Medicine, Monash University and Chairman, Department of Urology, Monash Health, Melbourne, Victoria, Australia.

He is currently the President of the Urological Society of Australia and New Zealand, and was the inaugural chairman, of the Urologic Oncology Special Advisory Group of this organisation. His main research interests are in the area of Urologic Oncology having published greater than 130 papers on clinical, epidemiological and psycho-oncology/survivorship aspects of all major urological cancers, with approximately 10 million dollars in grant funding in urological cancer research over the last 10 years.

This included being the principal investigator for the Victorian Cancer Agency funded CAPTIV collaboration ( CAncer of the Prostate Translational research In Victoria ). He has previously held board membership of Andrology Australia and was the inaugural chairman, Clinical Institute of Speciality Surgery, Epworth Healthcare. He is on the Executive committee of the World Urologic Oncology Federation, the Australian representative of the Asia-Pacific Society of Uro-Oncology, and is a regular reviewer for multiple major urologic journals, NHMRC and Prostate Cancer UK.

Peter Haylen
Mr Peter Haylen

Peter established the law firm, Haylen McKenzie in 1987 and remains a senior partner. He continues to practise, frequently as an advocate in the field of industrial law, succession and insolvency. Peter was diagnosed with prostate cancer in 2010.

He joined Prostate Cancer Foundation of Australia's NSW/ACT State Board in 2011, and was appointed a National Director in 2015. Peter is also a foundation member of Medicins Sans Frontiers, a cricket umpire, former manager of women's cricket teams and is a member of Flags Australia.

Jim Hughes AM
Mr Jim Hughes AM

Jim has had a ten year involvement with PCFA. He has held senior positions in the insurance industry throughout Australia over many years and is actively involved in community activities.

He is a Senior Associate of the Australian and New Zealand Institute of Insurance and Finance and a graduate of the Australian Institute of Company Directors.

He is a past lecturer on corporate risk management and business strategy formulation on behalf of the Australian Institute of Company Directors. Jim is a Director of Youi Insurance, Ambooriny Burru Charitable Foundation and KRED Enterprises Charitable Trust. He is also a patron of the Apex Foundation of Australia and a Life Governor of the Apex Clubs of Australia.

Andrew Kneebone
Associate Professor Andrew Kneebone

A/Professor Andrew Kneebone is a senior staff specialist in radiation oncology at the Royal North Shore and Gosford Hospitals as well as Genesis Cancer Care. He has nearly 20 years of experience as a prostate cancer specialist and is current co-chair of the national Radiation Oncology Genitourinary executive and has been an author on multiple National guidelines for definitive and post prostatectomy radiotherapy.

A/Prof Kneebone's has a strong interest in research and has been a Chief investigator in trials attracting more than $6 million in competitive grants. He is currently the co Chief Investigator for a major multi-centre randomised trial evaluating the optimal timing for post prostatectomy radiotherapy called the RAVES trial which has recently closed to recruitment. He has been the Principal Investigator in two completed randomised Australian trials looking at methods to reduce bowel damage arising from prostate radiotherapy and ways to better keep patients still during radiotherapy treatment. A/Prof Kneebone has also been listed as an author on more than 80 peer reviewed publications and has been invited speaker at more than 90 conferences or meetings.

A/Prof Kneebone is on numerous state and national committees related to the treatment of prostate cancer including several NHMRC advisory committees. He has been the Convener for eight national oncology conferences and has been on the organising committee for a further 13, A/Prof. Kneebone, was for six years, the Secretary of the NSW Genitourinary Oncology Group and was for several years the co-chair of the NSW Cancer Institute EVIQ radiotherapy protocols committee.

A/Prof. Kneebone remains a committed teacher to medical students and junior doctors. He is attached to and lectures at the University of Sydney and has been a Director of Registrar Training for more than 15 years. In 2014 he was awarded the Denise Lonergan award by the RANZCR for "outstanding level of commitment, participation and leadership in the area of training and education in radiation oncology over an extended period of time".

Bill Munro
Mr Bill Munro

Bill Munro has recently retired from a business career as a company director and merchant banker although remains involved as a strategic planning consultant. He is also a director and committee member of a number of not-for-profit organisations.

Bill is Chairman of PCFA in Western Australia and in the past has been Chairman of the Royal West Australian Institute for the Blind, a Director of Homeswest, and a Board member of the WA Theatre Company.

Bill is a Vietnam veteran and maintains his ex-service links through the Returned and Services League and the Royal Australian Regiment Association. He joined the Board of PCFA in Western Australia in 2011 and was appointed Deputy Chairman in 2012.

Mr John Palmer
B.A, B.Sc.App(Building) Class 1 Hons, FAIM, FAIB, MIAA, Chartered Builder, JP.

John is a Past President of the Rotary Club of Lane Cove and a Rotarian of 35 years. In 1997 he was the second Chairman of PCFA. He is a retired Associate Lecturer University of Technology Sydney. John is a Chartered Builder and the owner and sole director of Building Durability Pty Ltd, T A Taylor (Aust) Pty Ltd and Research & Applied Technologies Pty Ltd. In 1991 John established a joint venture with and was a Board Member of the TIANAO Building Repair Materials Institute in Tianjin China until 2002.

Geoff Underwood
Mr Geoff Underwood
Certificate of Business Studies (Real Estate)

Geoff Underwood joined the Victorian Board of PCFA in 2011 and became chairman in 2015. A prostate cancer survivor, his participation with PCFA represents a continuation of service over a long period at local, state and national levels with community groups, industry associations and government committees.

Following national service and duty in Vietnam for which he received a commendation from the Commander of Australian Forces in Vietnam for his "special contribution to Australia's war effort", Geoff worked in State Government from 1971 to 1981 when he moved to private industry. Since then he has run his own consultancies specialising in town planning advice, property development, demographics and urban economics. He is currently Managing Director of Spade Consultants Pty Ltd which offers those specialist services to government and private clients.

Geoff is recognised as a life member of community and industry groups and was awarded in 2015 for his "outstanding contributions to planning in Victoria".

Aprof Tony Walker
Associate Professor Tony Walker

Tony Walker ASM is the Chief Executive Officer of Ambulance Victoria. He has over 30 years' experience working in a range of senior clinical governance, education and operational roles and is also an adjunct Associate Professor in the College of Health and Biomedicine at Victoria University. Tony's academic qualifications include a Bachelor of Paramedic Studies, Graduate Diploma in Emergency Health and Master of Education and he is published in an extensive range of literature relating to advancements in paramedic care.

In 2010 Tony was diagnosed with Prostate Cancer at the age of 47 which was successfully treated with a radical prostatectomy and he has been an Ambassador with the Prostate Cancer Foundation of Australia since 2014. He has three adult children and is enjoying fatherhood the second time around with his little daughter Lucy.